The Brown CardioPulmonary Training Program has as its overall objective the training of physicians and scientists who will become independent investigators in the molecular basis and pathobiology of cardiovascular and pulmonary diseases and the outcomes of prevention and treatment of these diseases. This will be accomplished by a rigorous program of didactic training and mentored research experience in a collaborative, multidisciplinary setting with career development training. Four postdoctoral trainees with an MD, PhD, or MD/PhD degree will be accepted per year into a 3- year research training program. Thirty-three experienced and well-funded faculty trainers plus seven promising junior faculty trainers from 11 academic departments have developed a Training Program that utilizes resources from 7 Brown teaching hospitals plus Brown University. The Training Program aims to bridge gaps between bio-medical, behavioral and public health disciplines to advance knowledge regarding how best to reduce disease burden among patients with diseases that affect the cardiovascular system and lungs. This will be accomplished by training in Molecular Pathobiology of Cardiovascular and Pulmonary Diseases or in Health Services/Outcomes. This Training Program is uniquely positioned to train individuals in research related to diseases that involve these systems, such as aging. Having trainees looking at these problems from both bench to bedside and bedside to practice aspects can lead to new insights, lines of synergistic research and advances in science using both molecular methods and epidemiologic, clinical trials, and health services investigations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL094300-05
Application #
8323919
Study Section
Special Emphasis Panel (ZHL1-CSR-R (O2))
Program Officer
Carlson, Drew E
Project Start
2008-09-01
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2012
Total Cost
$210,026
Indirect Cost
$37,180
Name
Rhode Island Hospital
Department
Type
DUNS #
075710996
City
Providence
State
RI
Country
United States
Zip Code
02903
Cooper, Leroy L; Woodard, Todd; Sigurdsson, Sigurdur et al. (2016) Cerebrovascular Damage Mediates Relations Between Aortic Stiffness and Memory. Hypertension 67:176-82
Sabe, Ashraf A; Potz, Brittany A; Elmadhun, Nassrene Y et al. (2016) Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia. J Thorac Cardiovasc Surg 151:245-52
Potz, Brittany A; Sabe, Ashraf A; Abid, M Ruhul et al. (2016) Calpains and Coronary Vascular Disease. Circ J 80:4-10
Potz, Brittany A; Sabe, Ashraf A; Elmadhun, Nassrene Y et al. (2016) Calpain inhibition modulates glycogen synthase kinase 3β pathways in ischemic myocardium: A proteomic and mechanistic analysis. J Thorac Cardiovasc Surg :
Potz, Brittany A; Sabe, Ashraf A; Elmadhun, Nassrene Y et al. (2016) Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia. Surgery :
Koo, Patrick; McCool, F Dennis; Hale, Lauren et al. (2016) Association of obstructive sleep apnea risk factors with nocturnal enuresis in postmenopausal women. Menopause 23:175-82
Feng, Jun; Liu, Yuhong; Sabe, Ashraf A et al. (2016) Differential impairment of adherens-junction expression/phosphorylation after cardioplegia in diabetic versus non-diabetic patients. Eur J Cardiothorac Surg 49:937-43
Dalal, Rahul S; Sabe, Ashraf A; Elmadhun, Nassrene Y et al. (2015) Atrial Fibrillation, Neurocognitive Decline and Gene Expression After Cardiopulmonary Bypass. Braz J Cardiovasc Surg 30:520-32
Potz, Brittany A; Sabe, Ashraf A; Elmadhun, Nassrene Y et al. (2015) Calpain inhibition decreases myocardial apoptosis in a swine model of chronic myocardial ischemia. Surgery 158:445-52
Cooper, Leroy L; Rong, Jian; Benjamin, Emelia J et al. (2015) Components of hemodynamic load and cardiovascular events: the Framingham Heart Study. Circulation 131:354-61; discussion 361

Showing the most recent 10 out of 64 publications